1. EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
- Author
-
Sanchez-Vega, Francisco, primary, Hechtman, Jaclyn F., additional, Castel, Pau, additional, Ku, Geoffrey Y., additional, Tuvy, Yaelle, additional, Won, Helen, additional, Fong, Christopher J., additional, Bouvier, Nancy, additional, Nanjangud, Gouri J., additional, Soong, Joanne, additional, Vakiani, Efsevia, additional, Schattner, Mark, additional, Kelsen, David P., additional, Lefkowitz, Robert A., additional, Brown, Karen, additional, Lacouture, Mario E., additional, Capanu, Marinela, additional, Mattar, Marissa, additional, Qeriqi, Besnik, additional, Cecchi, Fabiola, additional, Tian, Yuan, additional, Hembrough, Todd, additional, Nagy, Rebecca J., additional, Lanman, Richard B., additional, Larson, Steven M., additional, Pandit-Taskar, Neeta, additional, Schöder, Heiko, additional, Iacobuzio-Donahue, Christine A., additional, Ilson, David H., additional, Weber, Wolfgang A., additional, Berger, Michael F., additional, de Stanchina, Elisa, additional, Taylor, Barry S., additional, Lewis, Jason S., additional, Solit, David B., additional, Carrasquillo, Jorge A., additional, Scaltriti, Maurizio, additional, Schultz, Nikolaus, additional, and Janjigian, Yelena Y., additional
- Published
- 2019
- Full Text
- View/download PDF